<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d430">
    <sentence id="DDI-DrugBank.d430.s0" text="Intravenous ranitidine was shown to double the bioavailability of oral alendronate.">
        <entity id="DDI-DrugBank.d430.s0.e0" charOffset="12-21"
            type="drug" text="ranitidine"/>
        <entity id="DDI-DrugBank.d430.s0.e1" charOffset="71-81"
            type="drug" text="alendronate"/>
        <pair id="DDI-DrugBank.d430.s0.p0" e1="DDI-DrugBank.d430.s0.e0"
            e2="DDI-DrugBank.d430.s0.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d430.s1" text="The clinical significance of this increased bioavailability and whether similar increases will occur in patients given oral H2-antagonists is unknown;">
        <entity id="DDI-DrugBank.d430.s1.e0" charOffset="124-137"
            type="group" text="H2-antagonists"/>
    </sentence>
    <sentence id="DDI-DrugBank.d430.s2" text="no other specific drug interaction studies were performed."/>
    <sentence id="DDI-DrugBank.d430.s3" text="Products containing calcium and other multivalent cations likely will interfere with absorption of alendronate.">
        <entity id="DDI-DrugBank.d430.s3.e0" charOffset="20-26"
            type="drug" text="calcium"/>
        <entity id="DDI-DrugBank.d430.s3.e1" charOffset="38-56"
            type="drug" text="multivalent cations"/>
        <entity id="DDI-DrugBank.d430.s3.e2" charOffset="99-109"
            type="drug" text="alendronate"/>
        <pair id="DDI-DrugBank.d430.s3.p0" e1="DDI-DrugBank.d430.s3.e0"
            e2="DDI-DrugBank.d430.s3.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d430.s3.p1" e1="DDI-DrugBank.d430.s3.e0"
            e2="DDI-DrugBank.d430.s3.e2" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d430.s3.p2" e1="DDI-DrugBank.d430.s3.e1"
            e2="DDI-DrugBank.d430.s3.e2" ddi="true" type="mechanism"/>
    </sentence>
</document>
